Andrea Markkula (Former)
1 – 20 of 21
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
The impact of body size changes on recurrence risk depends on age and estrogen receptor status in primary breast cancer
(
- Contribution to journal › Article
- 2018
-
Mark
Interactions between ABCB1genotype and preoperative statin use impact clinical outcomes among breast cancer patients
(
- Contribution to journal › Article
- 2017
-
Mark
Combined and individual tumor-specific expression of insulinlike growth factor-I receptor, insulin receptor and phosphoinsulin- like growth factor-I receptor/insulin receptor in primary breast cancer : Implications for prognosis in different treatment groups
(
- Contribution to journal › Article
-
Mark
The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size
(
- Contribution to journal › Article
-
Mark
High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort
(
- Contribution to journal › Article
-
Mark
Body mass index influences the prognostic impact of combined nuclear insulin receptor and estrogen receptor expression in primary breast cancer
(
- Contribution to journal › Article
- 2016
-
Mark
CYP1A2 - a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients
(
- Contribution to journal › Article
-
Mark
Impacts of smoking on endocrine treatment response in a prospective breast cancer cohort
(
- Contribution to journal › Article
- 2015
-
Mark
Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients.
(
- Contribution to journal › Article
-
Mark
Genetic factors, body constitution, and tumor characteristics in relation to breast cancer prognosis
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-based Prospective Cohort.
(
- Contribution to journal › Article
-
Mark
Caffeine and caffeic acid inhibit growth and modify estrogen receptor (ER) and insulin-like growth factor I receptor (IGF-IR) levels in human breast cancer.
(
- Contribution to journal › Article
-
Mark
History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response.
(
- Contribution to journal › Article
- 2014
-
Mark
IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort.
(
- Contribution to journal › Article
-
Mark
Pre- and postoperative alcohol consumption in breast cancer patients: impact on early events.
(
- Contribution to journal › Article
-
Mark
No association found between CYP2D6 genotype and early breast cancer events in tamoxifen-treated patients.
(
- Contribution to journal › Article
-
Mark
Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients.
(
- Contribution to journal › Article
-
Mark
37p * androgen receptor expression in a population-based prospective breast cancer cohort.
(
- Contribution to journal › Published meeting abstract
- 2013
-
Mark
Excessive milk production during breast-feeding prior to breast cancer diagnosis is associated with increased risk for early events.
(
- Contribution to journal › Article
- 2012
-
Mark
Clinical Profiles Predict Early Nonadherence to Adjuvant Endocrine Treatment in a Prospective Breast Cancer Cohort
(
- Contribution to journal › Article